Muscle Invasive Bladder Cancer

With at least one-quarter of bladder cancer patients presenting with deadly muscle-invasive tumors, decisions on staging and treatment are profound – yet must be made swiftly. Urologic cancer surgeon, Sima Porten, MD, offers the latest guidelines and study findings – including genomics research data – to help physicians guide each patient toward an optimal outcome.


May 7, 2020

Created by

UCSF MedConnection

Related Presenters

Sima P. Porten MD, MPH

Sima P. Porten MD, MPH

Urologic cancer surgeon

Dr. Sima Porten is a specialist in cancers of the genital and urinary organs. She is a member of the urologic oncology team at the UCSF Helen Diller Family Comprehensive Cancer Center. Her clinical interests include the diagnosis and treatment ...

View Profile